This inventor holds 1 USPTO granted patent. Top assignee: Teva Sante. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Joëlle Leyder: Innovator in Pharmaceutical Formulations
Introduction
Joëlle Leyder is a notable inventor based in Créteil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of innovative drug delivery systems. His work has led to advancements that enhance the efficacy and usability of medications.
Latest Patents
One of Joëlle Leyder's key inventions is a patent for a modafinil oral lyophilizate. This invention concerns an oral lyophilizate comprising modafinil particles with a median diameter of about 10 to about 1000 µm, in association with an appropriate amount of at least one excipient selected from the group consisting of fatty acid esters of glycerol, cyclic oligosaccharides, sweeteners, or mixtures thereof. This formulation aims to improve the delivery and effectiveness of modafinil, a medication used to treat sleep disorders.
Career Highlights
Joëlle Leyder is currently associated with Teva Santé, a leading global pharmaceutical company. His role at Teva Santé allows him to leverage his expertise in pharmaceutical formulations to develop innovative solutions that meet the needs of patients and healthcare providers.
Collaborations
Joëlle Leyder has collaborated with various professionals in the field, including his coworker Thanh-Tam Nguyen. These collaborations have fostered an environment of innovation and have contributed to the successful development of new pharmaceutical products.
Conclusion
Joëlle Leyder's contributions to the pharmaceutical industry, particularly through his patent for modafinil oral lyophilizate, highlight his role as an innovator in drug formulation. His work continues to impact the field positively, enhancing the delivery of essential medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile